Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/2010
04/01/2010US20100081687 Biarylcarboxyarylamides as vanilloid-1 receptor modulators
04/01/2010US20100081686 Pyridone derivatives having a binding activity to the cannabinoid type 2 recepter
04/01/2010US20100081683 Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
04/01/2010US20100081680 N-sulfonamido polycyclic pyrazolyl compounds
04/01/2010US20100081677 Heteroarylamide pyrimidone derivatives
04/01/2010US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
04/01/2010US20100081668 Polymorphs of 5--6-chloro-1,3-dihydro-2h-indol-2-one hydrobromide and processes for preparation thereof
04/01/2010US20100081667 Chemical Compounds
04/01/2010US20100081664 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
04/01/2010US20100081663 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
04/01/2010US20100081660 Novel Compounds Having Selective Inhibiting Effect at GSK3
04/01/2010US20100081659 Sigma receptor inhibitors
04/01/2010US20100081657 Quinoxalines useful as inhibitors of protein kinases
04/01/2010US20100081656 Compositions and methods for modulating c-kit and pdgfr receptors
04/01/2010US20100081651 R(-)-11-hydroxyaporphine derivatives and uses thereof
04/01/2010US20100081648 Methods for Characterizing and Treating Cognitive Impairment In Aging and Disease
04/01/2010US20100081647 Short-acting benzodiazepine salts and their polymorphic forms
04/01/2010US20100081645 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
04/01/2010US20100081642 Cb-1 receptor modulator pharmaceutical formulations
04/01/2010US20100081639 Pharmaceutical composition comprising fermented ginseng
04/01/2010US20100081625 Methods for preventing and treating neurodegenerative disorders
04/01/2010US20100081623 Novel tellurium compounds and their use as immunomodulators
04/01/2010US20100081617 Therapeutic agent for spinal cord injuries
04/01/2010US20100081614 Long-acting growth hormone and methods of producing same
04/01/2010US20100081613 Methods and compositions for enhancing memory
04/01/2010US20100080849 Pellets containing a pharmaceutical substance, method for the production thereof and use of the same
04/01/2010US20100080835 Implantable device for the delivery of risperidone and methods of use thereof
04/01/2010US20100080800 Humanized antibody
04/01/2010US20100080797 Therapy procedure for drug delivery for trigeminal pain
04/01/2010DE202010001237U1 Kombination aus Tramadol und Acetaminophen als Brausetablette Combination of tramadol and acetaminophen effervescent tablet
04/01/2010CA2738392A1 Process for the preparation of rotigotine
04/01/2010CA2738285A1 Method for producing lipids
04/01/2010CA2738282A1 Method for concentrating lipids
04/01/2010CA2738147A1 Solid pharmaceutical composition
04/01/2010CA2737645A1 Compounds which selectively modulate the cb2 receptor
04/01/2010CA2737639A1 Compounds which selectively modulate the cb2 receptor
04/01/2010CA2737252A1 Isoxazolo[4,5]pyridin-3-yl-piperazin derivatives useful as modulators of dopamine d3 receptors
04/01/2010CA2737031A1 Indole and indoline derivatives and methods of use thereof
04/01/2010CA2736724A1 Benzo[d]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine d3 receptors
04/01/2010CA2730002A1 Pyridinylpiperazin derivatives useful as modulators of dopamine d3 receptors
04/01/2010CA2725574A1 Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
03/2010
03/31/2010EP2169038A1 A process for decreasing environmental pollutants in an oil or a fat, and a fish feed product
03/31/2010EP2168984A1 Human antibodies that bind human IL-12 and methods for producing
03/31/2010EP2168968A1 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
03/31/2010EP2168960A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
03/31/2010EP2168959A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
03/31/2010EP2168955A1 Sleep-improving agent
03/31/2010EP2168950A1 Inhibitor of the differentiation of t cells into th1 cells
03/31/2010EP2168947A1 Novel compound having secretase inhibitory activity
03/31/2010EP2168586A1 Active ingredient of a medicinal agent, a medicinal agent, a pharmaceutical composition and method for treating dementia syndrome patients
03/31/2010EP2168585A1 Pharmaceuticals compositions of a neuroactive steroid and uses thereof
03/31/2010EP2168584A1 Pharmaceutical composition comprising the combination of a triazolobenzodiazepine and a selective serotonin reuptake inhibitor
03/31/2010EP2168580A1 Remedy or preventive for integration dysfunction syndrome
03/31/2010EP2168579A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
03/31/2010EP2168575A1 Medicinal agent for treating patients suffering from diseases caused by the monoaminooxidase excessive activity and a method for treating patients suffering from diseases caused by the monoaminooxidase excessive activity
03/31/2010EP2167509A1 Piperazine and ý1,4¨diazepan derivatives as nk antagonists
03/31/2010EP2167506A2 Method for producing n-methylnaltrexone bromide
03/31/2010EP2167501A1 Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators - 841
03/31/2010EP2167471A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
03/31/2010EP2167469A1 Sulfonyl-quinoline derivatives
03/31/2010EP2167460A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same
03/31/2010EP2167457A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same
03/31/2010EP2167135A2 Molecules for targeting compounds to various selected organs, tissues or tumor cells
03/31/2010EP2167115A2 Treatment for alzheimer's disease
03/31/2010EP2167113A2 Neuroplastin derived peptides
03/31/2010EP2167098A1 Allopregnanolone in a method for enhancing neurological function (alzheimer disease)
03/31/2010EP2167095A2 Compounds for treatment
03/31/2010EP2167092A2 Quinazoline derivatives as pi3 kinase inhibitors
03/31/2010EP2167091A1 Cinnoline compounds for use in the treatment of schizophrenia
03/31/2010EP2167083A2 Novel 1- heteroaryl-3-azabicycloý3.1.0¨hexanes, methods for their preparation and their use as medicaments
03/31/2010EP2167080A1 Pharmaceutical formulation comprising pramipexole
03/31/2010EP2166854A1 Triazole derivatives for treating alzheimer's disease and related conditions
03/31/2010EP2166852A1 Therapeutic pyrazoloquinoline derivatives
03/31/2010EP2076496B1 Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors
03/31/2010EP1758596B1 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
03/31/2010EP1756111B1 Alkyl substituted indoloquinoxalines
03/31/2010EP1675846B1 Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethylbenzyl)-5-pyridin-4-yl-1h- [1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
03/31/2010EP1630165B1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF
03/31/2010EP1620091B1 Inhibitors of glutaminyl cyclase
03/31/2010CN101687927A antibody directed to g protein coupled receptors (gpcr)
03/31/2010CN101687882A Non-basic melanin concentrating hormone receptor-1 antagonists
03/31/2010CN101687879A 5-furopyridinone substituted indazoles
03/31/2010CN101687878A Catecholamine derivatives useful for the treatment of parkinson' s disease
03/31/2010CN101687875A Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals
03/31/2010CN101687874A Pyrrolotriazine kinase inhibitors
03/31/2010CN101687858A 1, 3-dihydroimidazole- 2 -thione derivatives as inhibitors of dopamine-beta-hydroxylase
03/31/2010CN101687855A Phthalazinone derivatives and their use as medicament to treat cancer
03/31/2010CN101687850A Substituted pyrimidines as adenosine receptor antagonists
03/31/2010CN101687811A 4-imidazolines and their use as antidepressants
03/31/2010CN101687802A Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
03/31/2010CN101687799A Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
03/31/2010CN101687777A Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same
03/31/2010CN101687772A Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same
03/31/2010CN101687758A Substituted biphenyl carboxylic acids and derivatives thereof
03/31/2010CN101687047A Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
03/31/2010CN101687043A Coated oral nicotine formulation buffered with amino acid
03/31/2010CN101687032A Antagonist antibodies against ephb3
03/31/2010CN101687017A Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
03/31/2010CN101687011A New treatment for chemical substance addiction
03/31/2010CN101687004A Herbal formulation for treatment of depression and other related disorders and method of preparing the same
1 ... 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 ... 1833